Latest Operational Cash Flow News

Page 13 of 216
Enova Mining has reported encouraging rare earth exploration and metallurgical results across Brazil and Australia, but ended September with just A$333,000 in cash. A proposed A$2 million placement, A$495,200 rights issue and revised 25-for-1 consolidation now sit at the centre of its next phase.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Xenitra has returned to positive quarterly gross profit as its new pharmaceutical and Web3 businesses begin generating revenue, but statutory operating cash flow remained negative at A$790,000. The company is now relying on procurement targets, repeat Web3 sales and further capital discipline to turn early commercial activity into sustainable cash generation.
Victor Sage
Victor Sage
30 Oct 2026
Argent Minerals has added weight to the expansion case at its Kempfield silver project, with high-grade mineralisation extending beyond the current resource boundary. But the ASX-listed explorer ended September with A$1.725 million and an estimated 1.34 quarters of funding at its current cash outflow.
Maxwell Dee
Maxwell Dee
30 Oct 2026
I Synergy ended the September quarter with A$44,000 in cash and an estimated 0.76 quarters of funding, before securing A$200,000 in loan funding after quarter-end. Its proposed Macau digital economy partnership remains non-binding, while a prior half-year review flagged material uncertainty around going concern.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Third Age Health lifted first-half revenue 20.8% and statutory profit 38.4% as aged medical care services supplied almost all of the growth. The NZX-listed healthcare provider maintained its 4 cents per share quarterly dividend while warning that cybersecurity and technology investment could weigh on near-term earnings.
Ada Torres
Ada Torres
30 Oct 2026
Group 6 Metals has begun repaying A$11.5 million of debt ahead of schedule after cash rose to A$54.1 million at the end of September. The move strengthens the balance sheet, but repayment completion and the Dolphin mine’s ability to sustain cash generation remain key tests.
Maxwell Dee
Maxwell Dee
30 Oct 2026
PARKD has secured two early-stage contracts, added Symal as its exclusive partner in Victoria and South Australia, and lifted pro forma cash to about A$850,000 through a strategic placement. The progress comes against a sharp liquidity squeeze, with just A$53,000 in cash at 30 September and funding equivalent to 0.21 quarters before the raise.
Victor Sage
Victor Sage
30 Oct 2026
Oakridge International reported a $267,000 operating cash outflow for the September quarter, leaving $343,000 in cash and an estimated 1.28 quarters of funding. The healthcare technology company expects collections and customer orders to improve cash flow, while evaluating additional funding and continuing to manage a potential historical claim from Teko International.
Victor Sage
Victor Sage
30 Oct 2026
Echelon Resources has tied in Palm Valley 14, but output has fallen to around 0.5 TJ a day after pre-completion testing indicated 3-4 TJ a day. The company is funding its expanded drilling programme from operating cash flow while PV-15 moves towards expected first production in early 2027.
Victor Sage
Victor Sage
30 Oct 2026
Koba Resources has reported a 29-metre tin intersection grading 1.2% near the historic Gilmore Tin Mine in North Queensland, alongside tin mineralisation extending across 2km at Stannex. The company has started another 3,000m drilling program, but held only $1.97 million in cash at quarter-end and expects to seek equity funding.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Australian Bond Exchange generated $1.68 million in positive operating cash flow in Q1 FY27, lifting cash to $1.49 million while repaying $436,000 of borrowings. The result strengthens its balance sheet, though the quarter’s cash inflows included $263,000 in government grants or tax incentives and $150,000 of interest received.
Victor Sage
Victor Sage
30 Oct 2026
Syntara has reported statistically significant exploratory results for its Parkinson’s-related drug SNT-4728, while advancing blood-cancer and scar studies. The quarter also brought A$4.7 million in R&D funding, but the liquidation of a former buyer threatens a facility relocation and recovery of about A$0.6 million.
Ada Torres
Ada Torres
30 Oct 2026

Browse the archive

Full archive